Socinski, Mark A

Phase II trial of paclitaxel, ifosfamide, and carboplatin in extensive-stage small cell lung cancer. [electronic resource] - Lung cancer (Amsterdam, Netherlands) Apr 2003 - 91-7 p. digital

Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Multicenter Study

0169-5002

10.1016/s0169-5002(02)00527-5 doi


Adult
Aged
Antineoplastic Combined Chemotherapy Protocols--adverse effects
Carcinoma, Small Cell--drug therapy
Cisplatin--adverse effects
Female
Humans
Ifosfamide--adverse effects
Lung Neoplasms--drug therapy
Male
Middle Aged
Neoplasm Staging
Paclitaxel--adverse effects
Quality of Life
Survival Rate
Taxoids